200 related articles for article (PubMed ID: 3786246)
1. Proliferative activity in dysplasia, carcinoma in situ and microinvasive carcinoma of the uterine cervix.
Tanaka T
Pathol Res Pract; 1986 Oct; 181(5):531-9. PubMed ID: 3786246
[TBL] [Abstract][Full Text] [Related]
2. [The changes in nuclear DNA amounts in the development and progression of uterine cervical cancer determined by cytofluorometry].
Harada K
Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):759-68. PubMed ID: 3722955
[TBL] [Abstract][Full Text] [Related]
3. [Nuclear DNA content and chromosomal counts of cultured cells derived from human cervix with normal and abnormal epithelia].
Hayakawa O; Kusanagi T; Kudo R
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):229-36. PubMed ID: 3973446
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis and cell growth fraction in normal, dysplastic and neoplastic squamous epithelium of uterine cervix].
Furuya H; Yabushita H; Noguchi M; Nakanishi M
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):141-8. PubMed ID: 7706854
[TBL] [Abstract][Full Text] [Related]
5. [Human papilloma virus (HPV) antigens and DNA in dysplasia and carcinoma of the uterine cervix].
Yamagata S; Tsuchida S; Yamamoto K; Kawamura N; Nakamura T; Ueki S; Sugawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1334-40. PubMed ID: 2555425
[TBL] [Abstract][Full Text] [Related]
6. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
Khaled A; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric classification of biopsy specimens from cervical intraepithelial neoplasia.
Jakobsen A; Kristensen PB; Poulsen HK
Cytometry; 1983 Sep; 4(2):166-9. PubMed ID: 6628138
[TBL] [Abstract][Full Text] [Related]
8. [DNA-content of mitotic cells in dysplasia and carcinoma in situ of the uterine cervix (author's transl)].
Wagner D
Verh Dtsch Ges Pathol; 1973; 57():211-4. PubMed ID: 4142178
[No Abstract] [Full Text] [Related]
9. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
Jaworski RC
Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies on intravaginal administration of CDDP for dysplasia, carcinoma in situ and microinvasive carcinoma of the uterine cervix].
Nakayama K; Sano Y; Endo Y; Sato H; Ohyama T; Yamaguchi M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):208-14. PubMed ID: 1545173
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
Murakami T; Nagai N; Ota S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
[TBL] [Abstract][Full Text] [Related]
12. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
13. DNA analysis in precancerous (dysplasia) and cancerous lesions of uterine cervix.
Kashyap V; Das DK; Luthra UK
Indian J Cancer; 1988 Dec; 25(4):207-17. PubMed ID: 3243569
[No Abstract] [Full Text] [Related]
14. [DNA content in dysplasias and early invasive forms of cervical cancer].
Chebanu FA; Kushch AA; Zelenin AV
Vopr Onkol; 1977; 23(12):64-6. PubMed ID: 602080
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
Ueda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
[TBL] [Abstract][Full Text] [Related]
16. Conization for cervical dysplasia and carcinoma in situ: long term follow-up of 1013 women.
Larsson G
Ann Chir Gynaecol; 1981; 70(2):79-85. PubMed ID: 7316444
[TBL] [Abstract][Full Text] [Related]
17. Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins.
Kurman RJ; Jenson AB; Lancaster WD
Am J Surg Pathol; 1983 Jan; 7(1):39-52. PubMed ID: 6299124
[TBL] [Abstract][Full Text] [Related]
18. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining.
Kobayashi I; Matsuo K; Ishibashi Y; Kanda S; Sakai H
Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076
[TBL] [Abstract][Full Text] [Related]
19. [Preinvasive lesions and their treatment].
Sidney H; Mage G; Bruhat MA
Rev Prat; 1990 Jan; 40(1):12-8. PubMed ID: 2300758
[TBL] [Abstract][Full Text] [Related]
20. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
Nishiya I; Ishizaki Y; Sasaki M
Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
